Menu

ADC Therapeutics SA ADCT

Full chart Compare
Set alert

Price alert · ADCT

All alert types
1.58 USD -0.06 (-3.66%)

At closeNov 6, 2026, 4:39 PM EST

1.53 -0.05 -3.16%

After hours · Nov 6, 4:39 PM ET

1.52 Day range 1.64
0.96 52-week range 4.88
YTD
-55.24%
1 year
-62.02%

Revenue & Expenses

Revenue by
Income Tax Benefit → Expenses: $157.00KProduct → Revenue: $73.55MExpenses → Research & Development: $104.00MExpenses → Other Operating Expenses: $84.87MExpenses → Other Expenses: $34.40MGross Profit → Expenses: $73.68MRevenue → Gross Profit: $73.68MRevenue → Cost of Revenue: $7.67MLicense Revenues → Revenue: $5.00MNet Loss → Expenses: $142.62MRoyalty Revenue → Revenue: $2.81MIncome Tax Benefit$157.00KGross Profit$73.68MNet Loss$142.62MCost of Revenue$7.67MExpenses$216.46MResearch & Development$104.00MOther Operating Expenses$84.87MOther Expenses$34.40MRevenue$81.36MProduct$73.55MLicense Revenues$5.00MRoyalty Revenue$2.81M

Latest period ending Dec 31, 2025 · select a line to chart its full history

ADCT annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
81.36M70.84M69.56M209.91M33.92M
75.56M64.89M67.03M206.61M32.52M
-121.50M-130.65M-165.99M-123.34M-261.72M
-142.62M-157.85M-240.05M-157.13M-230.03M
-1.12-1.62-2.94-2.01-3.00
ADCT annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
261.34M250.87M278.60M326.44M466.54M
323.15M321.98M354.78M490.86M617.97M
508.98M524.62M503.03M411.41M451.88M
116.49M121.63M122.91M117.38M139.70M
-185.83M-202.64M-148.25M79.45M166.09M
ADCT annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-141.17M-123.83M-118.69M-138.31M-227.50M
395.00K-867.00K-3.22M-687.00K-6.67M
150.94M97.05M73.88M-897.00K267.39M
395.00K-867.00K-3.22M-687.00K-3.43M
10.17M-27.65M-48.03M-139.90M27.34M